Schlagwort: Sciencedayly
Breast cancer classified into 12 unique biological groups
9. Dezember 2021
Researchers have demonstrated a major step forward in melding two key methods for studying breast cancer: one by genetic analysis and the second by looking at the architecture of cells, or their pathology. Using The Cancer Genome Atlas Breast Cancer Data set, they developed classification method that divides breast cancers into 12 distinct biological groups. This could aid future research efforts and enable faster translation of molecular findings into the pathology lab for clinical use, they report.
CRISPR/Cas9 gene editing boosts effectiveness of ultrasound cancer therapy
9. Dezember 2021
Sonodynamic therapy uses ultrasound in combination with drugs to release harmful reactive oxygen species (ROS) at the site of a tumor. However, the treatment isn’t very effective because cancer cells can activate antioxidant defense systems to counteract it. Now, researchers have breached these defenses with CRISPR/Cas9 gene editing, allowing sonodynamic therapy to effectively shrink tumors in a mouse model of liver cancer.
Researchers develop an antibody-drug delivery system
8. Dezember 2021
Researchers have developed the first metal-organic framework (MOFs) antibody-drug delivery system that has the potential to fast-track potent new therapies for cancer, cardiovascular and autoimmune diseases.
Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients
8. Dezember 2021
A recent phase II clinical trial results suggest that the monoclonal antibody hu14.18K322A could help change treatment of children with high-risk neuroblastoma.
Researchers crack the synthetic code of rare molecules sought after in drug development
7. Dezember 2021
A research team has succeeded in producing two molecules that are otherwise only formed by microorganisms from extremely contaminated wastewater in an abandoned mine in South Korea. The method, which took four years to develop, could pave the way for new types of drugs.
Glucose control is a key factor for reduced cancer risk in obesity and type 2 diabetes
7. Dezember 2021
Good glucose control is important for reduction of cancer risk in obesity and type 2 diabetes. Large durable weight loss, as such, appears to afford protection against cancer, but with good glucose control the number of cancer cases also drops radically, a new study shows.
Immune system-stimulating nanoparticle could lead to more powerful vaccines
4. Dezember 2021
Researchers designed a new nanoparticle adjuvant that may be more potent than others now in use. Studies in mice showed it significantly improved antibody production following vaccination against HIV, diphtheria and influenza.
Scientists pinpoint protein’s role in critical gene expression
3. Dezember 2021
New research has implications for cancer research because it explains part of the paradox for how cells can transcribe genes in the absence of high-energy sources, a situation that unfolds in cancer and has puzzled researchers for years.
Harnessing the organization of the cell surface
3. Dezember 2021
Scientists have developed a new method to determine how proteins are organized on the surface of cells. Insights gained with the technology could lead to the development of novel drugs to fight cancer.
Magnetic resonance imaging (MRI) and artificial intelligence (AI) can detect early signs of tumor cell death after novel therapy
2. Dezember 2021
A recent study demonstrates that magnetic resonance imaging (MRI) and artificial intelligence (AI) can be used to detect early signs of tumor cell death in response to a novel virus-based cancer therapy.
Targeting the brain’s immune cells may help prevent or treat Alzheimer’s disease
2. Dezember 2021
A gene mutation linked to Alzheimer’s disease alters a signaling pathway in certain immune cells of individuals with the disease, according to a new study. The team also found that blocking the pathway — with a drug that’s currently being tested in cancer clinical trials — protects against many features of the condition in a preclinical model. The results could lead to new strategies to block the development of Alzheimer’s disease or slow its progression.
Discovery of a Stem-like T cell in type 1 diabetes holds potential for improving cancer immunotherapy
2. Dezember 2021
As an autoimmune disease, Type 1 diabetes raises important questions about immune cell activity that have broad implications for immunotherapy.
Biosensor barcodes identify, detail ‘chatting’ among cancer cells
2. Dezember 2021
Ever since the first barcode appeared on a pack of chewing gum in 1974, the now-ubiquitous system has enabled manufacturers, retailers and consumers to quickly and effectively identify, characterize, locate and track products and materials. Scientists now demonstrate how they can do the same thing at the molecular level, studying the ways cancer cells ‚talk‘ with one another.
Which glioblastoma patients will respond to immunotherapy?
2. Dezember 2021
Scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy. The treatment could extend survival for an estimated 20% to 30% of patients. Currently, patients with glioblastoma do not receive this life-prolonging treatment because it has not been fully understood which of them could benefit.
Successful treatment in mice for severe childhood cancer
2. Dezember 2021
In mice with high-risk neuroblastoma, tumors disappeared in response to a new combination treatment with precision medicines, a recent study shows. This is a vital step toward a potentially curative treatment for a form of cancer affecting young children that is currently difficult to treat.
Parallels in human, dog oral tumors could speed new therapies
30. November 2021
Recent research compared the genetic expression profiles of a nonlethal canine tumor and the rare, devastating human oral tumor it resembles, laying the groundwork for potential translational medicine down the road.
How moles change into melanoma
24. November 2021
Melanoma researchers published a study that gives a new explanation of what causes moles to change into melanoma. These findings pave the way for more research into how to reduce the risk of melanoma, delay development, and detect melanoma early.
Chemotherapy may affect muscle cells at lower doses than previously thought
24. November 2021
Previous research has found that chemotherapy can trigger muscle loss in people living with cancer, but a new study out of found it may also affect the way the body builds new muscle — and at lower doses than previously known, having potential implications for treatments and rehab programs.
Strategy to overcome tumors’ resistance to immunotherapy generates promising clinical trial results
24. November 2021
Immune checkpoint inhibitors strengthen the immune response against cancer cells, but the medications are ineffective against certain tumors. Results from a new clinical trial indicate that adding radiation may overcome this resistance to immune checkpoint inhibitors.
New imaging technology may reduce need for skin biopsies
20. November 2021
A new ‚virtual histology‘ technology shows promise by analyzing images of suspicious-looking lesions and quickly producing a detailed, microscopic image of the skin, bypassing several standard steps typically used for diagnosis — including skin biopsy, tissue fixation, processing, sectioning and histochemical staining.
New findings on the link between CRISPR gene-editing and mutated cancer cells
19. November 2021
A protein that protects cells from DNA damage, p53, is activated during gene editing using the CRISPR technique. Consequently, cells with mutated p53 have a survival advantage, which can cause cancer. Researchers have found new links between CRISPR, p53 and other cancer genes that could prevent the accumulation of mutated cells without compromising the gene scissors‘ effectiveness.
Exercise increases the body’s own ‘cannabis-like‘ substance which reduces chronic inflammation
18. November 2021
Exercise increases the body’s own cannabis-like substances, which in turn helps reduce inflammation and could potentially help treat certain conditions such as arthritis, cancer and heart disease.
Shape-morphing microrobots deliver drugs to cancer cells
18. November 2021
Chemotherapy successfully treats many forms of cancer, but the side effects can wreak havoc on the rest of the body. Delivering drugs directly to cancer cells could help reduce these unpleasant symptoms. Now, in a proof-of-concept study, researchers have made fish-shaped microrobots that are guided with magnets to cancer cells, where a pH change triggers them to open their mouths and release their chemotherapy cargo.
Outcomes for hospitalized COVID-19 patients taking immunosuppressive medications similar to non-immunosuppressed patients, study finds
17. November 2021
A study of more than 200,000 U.S adults hospitalized with COVID-19 finds that, overall, patients taking immunosuppressive drugs do not face increased risk of being put on a ventilator or death.
The prostate cancer cell that got away
17. November 2021
Researchers have pioneered a new method to track the progression of prostate cancer in mice, from its birth to its spread into other tissues. This approach allows researchers to study the origins of prostate cancer in a more realistic context than traditional methods allow.